Loading organizations...
Loading organizations...
Preclinical drug discovery company using computational expertise.
Alivexis has raised $52.8M across 3 funding rounds.
Alivexis has raised $52.8M in total across 3 funding rounds.
Alivexis has raised $52.8M in total across 3 funding rounds.
Alivexis's investors include Green Co-Invest Investment, Heights Capital Management, Jafco Ventures, Keio Innovation Initiative, Yusuke Matsumoto, Takahiro Mizumoto, Dai-ichi Life, Essential Pharma, Miwa Toyoda, Kotaro Yamagishi, Medifuture, Mizuho Capital.
Alivexis has raised $52.8M across 3 funding rounds. Most recently, it raised $20.3M Series C in March 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 3, 2022 | $20.3M Series C | Green Co-Invest Investment, Heights Capital Management, Jafco Ventures, Keio Innovation Initiative, Yusuke Matsumoto, Takahiro Mizumoto | |
| May 13, 2020 | $25.3M Series B | Dai-ichi Life, Essential Pharma, Miwa Toyoda, Kotaro Yamagishi, Medifuture, Mizuho Capital, Mobile Internet Capital, Koki Hirota, SMBC Venture Capital, UTokyo Innovation Platform | |
| Aug 9, 2018 | $7.2M Series A | Hisashi Mitsuguchi, Keiichi Masuya |